Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000705732 | SCV000834745 | likely pathogenic | Dystonia 12 | 2018-06-14 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. A different nucleotide substitution (c.2677G>A) resulting in the same amino acid change at this codon (p.Gly893Arg) has been reported as de novo in an individual affected with alternating hemiplegia of childhood (PMID: 24842602). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has been observed to be de novo in individuals affected with Dystonia (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 893 of the ATP1A3 protein (p.Gly893Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. |